
Five weeks of radiation therapy is just as effective as eight weeks of radiation treatment for men with high-risk prostate cancer, according to new research presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Senior Editor, Diagnostic Imaging

Five weeks of radiation therapy is just as effective as eight weeks of radiation treatment for men with high-risk prostate cancer, according to new research presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

The retrospective study of patients 21 years of age or younger found that a deep learning algorithm and use of the American College of Radiology’s Thyroid Imaging Reporting and Data System (TI-RADS) both had more than a 26 percent greater sensitivity for differentiating thyroid nodules on ultrasound in comparison to radiologist assessment.

For physicians performing radiotherapy treatment of soft tissue tumors in the head and neck, the MRCAT Head and Neck offers an artificial intelligence (AI) application that allows the use of magnetic resonance imaging (MRI) as the primary or sole imaging for procedure planning.

Plaque Analysis and RoadMap Analysis, two artificial intelligence (AI)-enabled assessment products, may enhance clinical evaluation of coronary artery disease (CAD) on cardiac computed tomography angiography (CCTA).

In a recent letter to U.S. Rep. Rosa DeLauro (D-CT), the Food and Drug Administration (FDA) said a final rule on amendments to the Mammography Quality Standards Act (MQSA), including an oft-delayed national standard for breast density notification in mammography reporting, may be published in the next couple of months.

The inclusion of digital bismuth germanate (BGO) detector material with the Omni Legend system reportedly more than doubles the sensitivity of older PET/CT devices, improves scan times, and enhances the detection of small lesions.

Out of 1,600 patients who had surgery for colorectal cancer, nearly 15 percent had pulmonary metastases within 15.4 months and higher-risk patients experienced lung metastases within three months, according to new research presented at the Scientific Forum of the American College of Surgeons Clinical Congress.

In a recent video interview, Andrew Trout, MD discussed key attributes and efficiencies in utilizing the Discovery MI Gen 2 digital positron emission tomography/computed tomography (PET/CT) system at the Cincinnati Children’s Hospital Medical Center.

A multi-year agreement with a large Chile-based supplier of raw iodine is part of GE Healthcare’s commitment to increase the production of iodinated contrast media, commonly used in computed tomography imaging, by 30 million annually in 2025.

An emerging radiomics model, derived from 68Ga-PSMA-11 PET, reportedly offers a superior area under the curve (AUC) and higher sensitivity than radiologist assessment in detecting intraprostatic lesions via positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer.

In a large retrospective review of over four million Medicare claims, researchers found that Black women were 16 percent less likely to have access to digital breast tomosynthesis than White women.

While current consensus guidelines do not recommend the use of brain MRI screening in patients with breast cancer, a new study shows significantly elevated risks for the development of central nervous system metastasis in patients with inflammatory breast cancer.

Incorporating artificial intelligence (AI)-based technology, Neosoma HGG reportedly demonstrated a 95.5 percent accuracy rate in measuring brain tumor volume on brain magnetic resonance imaging (MRI) scans at various points during the treatment of patients with high-grade gliomas.

In a wide-ranging video interview, Wendie Berg, MD, PhD, discussed her family history with breast cancer, the founding of DenseBreast-info.org, emerging research with contrast-enhanced mammography and the need for a national standard on breast density notifications.

In a large study of nearly 100,000 women, researchers found that the combination of digital breast tomosynthesis (DBT) and synthesized mammography had more than triple the detection rate for invasive breast cancer in extremely dense breasts in comparison to digital mammography alone.

TeraRecon Neuro reportedly offers six automated and customizable computed tomography (CT) perfusion maps that facilitate assessment of brain function in hemorrhagic and ischemic neurological cases.

Modifications to pack-year history and smoking quit duration thresholds beyond those recommended in the 2021 United States Preventative Services Task Force (USPSTF) criteria for low-dose computed tomography lung cancer screening may more than double the number of increased lung cancer cases physicians would see with application of the 2021 USPSTF screening criteria.

In a study involving nearly 700 patients with atypical ductal or lobular hyperplasia, or lobular carcinoma in situ, researchers found no difference in four-year breast cancer detection rates between women who had screening mammography and breast magnetic resonance imaging (MRI), and women who only had mammography screening.

Offering the benefits of real-time collaboration and integrated connectivity, the portable ultrasound device may be utilized in a variety of clinical settings ranging from cardiology to obstetrics and gynecology.

Researchers found that in utero opioid exposure resulted in seven out of 14 2D biometric measurements of the fetal brain being smaller on magnetic resonance imaging (MRI) scans in comparison to fetuses without opioid exposure.

AIR Recon DL, a deep learning-based image reconstruction software, will now be available with 3D sequences as well as PROPELLER motion-insensitive sequences on magnetic resonance imaging (MRI) scanners from GE Healthcare.

In light of recent shortages of iodinated contrast media, researchers from Australia suggest in a new publication that ultrasound and magnetic resonance imaging (MRI) can be viable first-line imaging options for a number of non-urgent presentations of the head and neck.

Assessing data from 386,590 women, researchers noted that women with extremely dense breast tissue have more than double the risk for breast cancer in comparison to women with average breast density and nearly four times the risk of women with extremely fatty breast tissue.

One prospective multicenter study found the radiohybrid prostate-specific membrane antigen (PSMA) agent 18F-rhPSMA-7.3 had an 83 percent detection rate in nearly 400 men with suspected prostate cancer.

In an update of the original CAD-RADS™ consensus document on coronary artery disease (CAD) imaging and reporting published in 2016, expert panelists incorporated emerging evidence for CAD-RADS 2.0 to recommend new categorization for coronary plaque burden and suggested modifiers to reflect the level of ischemia and high-risk plaque in patients undergoing cardiac computed tomography.

The ability of QT Imaging’s QTscan, a quantitative transmission ultrasound modality, to calculate the ratio of fibroglandular volume to total breast volume may facilitate assessment of ongoing breast cancer treatments or selective hormone receptor modulation therapies.

Requiring only half of the gadolinium dose of current non-specific gadolinium-based contrast agents (GBCAs), gadopiclenol can be utilized with magnetic resonance imaging (MRI) to help detect lesions with abnormal vascularity in the central nervous system and other areas of the body.

In a retrospective review involving over 2.2 million women with three consecutive biennial mammography screenings and no history of breast cancer, researchers noted that for premenopausal women with fatty breasts at baseline, increasing breast density at subsequent screenings led to significantly elevated hazard ratios ranging from 1.45 to 1.93 for the risk of breast cancer.

Emerging research suggests that combining pre-biopsy magnetic resonance imaging (MRI) with prostate-specific antigen (PSA) testing more than triples the specificity rate for detecting clinically significant prostate cancer in comparison to sole reliance on a PSA level greater than or equal to 4 ng/mL.

Version 2.1 of the ClearPoint Neuro Navigation software reportedly offers enhanced imaging and new trajectory planning tools for neurosurgical procedures.